Skip to main content

Table 1 Table of baseline information of MTF1 high and low expression groups constructed based on TCGA database

From: Biological characterization and clinical significance of cuproptosis-related genes in lung adenocarcinoma

Characteristics

Low expression of MTF1

High expression of MTF1

P value

n

269

270

 

Pathologic T stage, n (%)

  

0.644

   T1

83 (15.5%)

93 (17.4%)

 

   T2

148 (27.6%)

144 (26.9%)

 

   T3

28 (5.2%)

21 (3.9%)

 

   T4

10 (1.9%)

9 (1.7%)

 

Pathologic N stage, n (%)

  

0.458

   N0

177 (33.8%)

173 (33.1%)

 

   N1

54 (10.3%)

43 (8.2%)

 

   N2

32 (6.1%)

42 (8%)

 

   N3

1 (0.2%)

1 (0.2%)

 

Age, median (IQR)

66 (58, 73)

66 (60, 72)

0.641

   Gender, n (%)

  

0.577

   Female

141 (26.2%)

148 (27.5%)

 

   Male

128 (23.7%)

122 (22.6%)

 

Pathologic stage, n (%)

  

0.873

   I 期

147 (27.7%)

149 (28.1%)

 

   II 期

64 (12.1%)

61 (11.5%)

 

   III 期

41 (7.7%)

43 (8.1%)

 

   IV 期

11 (2.1%)

15 (2.8%)